| Myanmar (Burma) | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 136.8 (2020) [115/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 1.8 (2020) [145/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 2.0 (2020) [117/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 22.0 (2020) [172/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 22.6 (2020) [42/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 9.5 (2020) [108/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 2.7 (2020) [144/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 1.7 (2020) [17/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 1.0 (2020) [157/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 2.6 (2020) [42/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 3.2 (2020) [136/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 4.4 (2020) [26/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 10.0 (2020) [29/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 15.7 (2020) [78/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 3.4 (2020) [102/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 0.4 (2020) [159/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 3.7 (2020) [9/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 3.7 (2020) [152/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 7.3 (2020) [16/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 1.1 (2020) [58/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 6.3 (2020) [89/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 1.4 (2020) [158/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 4.0 (2020) [178/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 13.7 (2020) [16/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 0.6 (2020) [115/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 2.7 (2020) [118/184countries] | | |
|
| Myanmar (Burma) | | |
Suicide, age-standardized (per 100 000 population) | 2.96 (2019) [162/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 5.09 (2019) [160/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 1.09 (2019) [168/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 3.39 (2019) [140/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 5.63 (2019) [122/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 1.17 (2019) [161/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 4.03 (2019) [157/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 6.96 (2019) [146/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 1.21 (2019) [166/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 3.74 (2019) [164/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 6.51 (2019) [158/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 1.15 (2019) [165/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 3.31 (2019) [164/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 5.63 (2019) [165/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 1.29 (2019) [167/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 4.06 (2019) [163/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 7.17 (2019) [161/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 1.61 (2019) [157/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 5.46 (2019) [156/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 9.53 (2019) [151/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 2.56 (2019) [147/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 6.42 (2019) [159/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 11.48 (2019) [155/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 3.28 (2019) [144/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 12.59 (2019) [151/183countries] | | |
|
|